[1]
“The Effects of Glucagon-Like Peptide-1 Receptor Agonists of Liraglutide on Bone Turnover Makers Among Type 2 Diabetes Mellitus Patients: A Meta-Analysis of Randomized Controlled Trials”, acbr, vol. 6, no. 1, pp. 134–144, Feb. 2022, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/14898